1.
Omar RMK, Najar AM, Bobtaina E, Elsheikh AF. Pryazolylpyridine and Triazolylpyridine derivative of hydroxychloroquine as Potential Therapeutic against COVID-19: Theoretical Evaluation. J. Drug Delivery Ther. [Internet]. 2020 Aug. 16 [cited 2026 Jan. 22];10(4-s):181-6. Available from: https://jddtonline.info/index.php/jddt/article/view/4298